The aim of the study is to generate real-world evidence to describe the patient experience of administration of Somatuline® Autogel® (lanreotide) in homecare and hospital settings, and the associated impact on healthcare utilisation, societal cost, work productivity and health-related quality of life (HRQoL)
Study Type
OBSERVATIONAL
Enrollment
80
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Cardiff and Vale University LHB
Cardiff, United Kingdom
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, United Kingdom
Liverpool University Hospitals NHS Foundation Trust
Liverpool, United Kingdom
Patient preferences of treatment administration setting (homecare or hospital)
Survey responses of patient experience of injections at home and compared to responses of patient experience of injections when given in hospital
Time frame: Baseline
Demographic characteristics of enrolled patients with GEP-NETs
Age (years); Gender (male, female); Current employment status: full time, part time, unemployed, retired, student, homemaker, unpaid carer)
Time frame: Baseline
Clinical characteristics of enrolled patients with GEP-NETs
Disease duration; Duration of homecare administration of lanreotide; Duration of hospital administration of lanreotide
Time frame: Baseline
Patient-reported impact on healthcare resource use
Assessed using bespoke questionnaire a patient-reported opinion on how homecare administration compares to hospital administration (i.e. much worse / somewhat worse / about the same / somewhat better / much better) for the number of administration setting related aspects described in the protocol, as well as choosing the most applicable answer(s) where applicable.
Time frame: Baseline
Patient-reported impact on wider societal costs
Assessed using bespoke questionnaire a patient-reported opinion on how homecare administration compares to hospital administration (i.e. much worse / somewhat worse / about the same / somewhat better / much better) for the number of administration setting related aspects described in the protocol, as well as choosing the most applicable answer(s) where applicable.
Time frame: Baseline
Patient-reported work productivity
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Royal Free London NHS Foundation Trust
London, United Kingdom
Assessed using the Work Productivity and Activity Impairment Questionnaire: General Health (WPAI:GH) and bespoke questionaire
Time frame: Baseline
Description of patient-reported HRQoL
Assessed using bespoke questionnaire a patient-reported opinion on how homecare administration compares to hospital administration (i.e. much worse / somewhat worse / about the same / somewhat better / much better) for the number of administration setting related aspects described in the protocol, as well as choosing the most applicable answer(s) where applicable.)
Time frame: Baseline
Description of patient experience of taking lanreotide in the hospital and homecare settings and reported benefits/limitations of each setting;
Assessed using qualitative interviews which will be conducted over the telephone by an experienced qualitative interviewer. During the interview semi-structured interview guide will be used, based on guidance and feedback from a clinical expert (specialist nurse) and patient expert(s). The interviews will be primarily guided by the questions in the discussion guide; however, participants will be free to direct the conversation to topics they feel are relevant to their experience.
Time frame: 1 month
Description of the impact of the homecare and hospital settings on HRQoL, work productivity, emotional and physical health
Assessed using qualitative interviews which will be conducted over the telephone by an experienced qualitative interviewer. During the interview semi-structured interview guide will be used, based on guidance and feedback from a clinical expert (specialist nurse) and patient expert(s). The interviews will be primarily guided by the questions in the discussion guide; however, participants will be free to direct the conversation to topics they feel are relevant to their experience.
Time frame: 1 month